GeoVax Labs (GOVX) Stock Statistics & Valuation Metrics

GeoVax Labs has a market cap or net worth of $7.75M. The enterprise value is $1.76M.

GeoVax Labs has 3,473,260 shares outstanding. The number of shares has decreased by -2.65% in one year.

GeoVax Labs’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.

The current PE Ratio of GeoVax Labs is ―. GeoVax Labs’s PEG ratio is 0.00235.

In the last 12 months, GeoVax Labs had revenue of 2.49M and earned -21.46M in profits. Earnings per share was -22.40.

In the last 12 months, operating cash flow was -19.05M and capital expenditures -5.00, giving a free cash flow of -19.05M billion.

GeoVax Labs pays an annual dividend of ―, resulting in a dividend yield of ―

GeoVax Labs upcoming earnings date is Aug 12, 2026, TBA (Confirmed).

GeoVax Labs as a current ratio of 2.74, with Debt / Equity ratio of 79.91%

In the past 12 months, GeoVax Labs has paid 0.00 in taxes.

GeoVax Labs EV to EBITDA ratio is 103.64K, with an EV/FCF ratio of 104.30K.

GeoVax Labs has $1.27M in cash and marketable securities with $394.57K in debt, giving a net cash position of $877.19K billion.

Gross margin is 102.54%, with operating margin of -869.34%, and net profit margin of -862.34%.

The average price target for GeoVax Labs is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy